ProtoLytic Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 11


  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.41M

  • Investors
  • 1

ProtoLytic General Information


Developer of decision support tools intended to help clients with medical cost management. The company's platform offers a treatment plan using statistical and clinical modeling for the patients based on guidelines and the interdependencies between related diagnosis and patient demographic data, enabling insurance companies, employers, and third-party administrators to evaluate, process, and fulfill medical service requests quickly and consistently in order to optimize treatment results, improve patient well-being and increase patient satisfaction with care.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Practice Management (Healthcare)
Primary Office
  • 3225 South MacDill Avenue
  • Suite 129-357
  • Tampa, FL 33629
  • United States
+1 (813) 000-0000

ProtoLytic Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProtoLytic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 09-Mar-2022 $1.41M 000.00 Completed Generating Revenue
6. Debt - PPP 14-May-2020 000.00 Completed Generating Revenue
5. Later Stage VC 10-Sep-2019 Cancelled Startup
4. Later Stage VC 18-Apr-2019 000 000.00 0000 Completed Startup
3. Early Stage VC 000 00.00 Completed Startup
2. Early Stage VC $6M $6.1M Completed Startup
1. Angel (individual) 27-Feb-2015 $100K $100K Completed Startup
To view ProtoLytic’s complete valuation and funding history, request access »

ProtoLytic Executive Team (7)

Name Title Board Seat Contact Info
Tom Sweet Jr. Chief Operating Officer
Leonard Kleinrock Ph.D Managing Director & Board Member
Alex Chang Managing Director
Patrick Schopke Managing Director
Bridgette Summers Chief Administrative Officer, Managing Director, Executive Vice President & Board Member
You’re viewing 5 of 7 executive team members. Get the full list »

ProtoLytic Board Members (1)

Name Representing Role Since
Leonard Kleinrock Ph.D ProtoLytic Managing Director & Board Member 000 0000
To view ProtoLytic’s complete board members history, request access »

ProtoLytic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProtoLytic Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CDH Ventures Venture Capital Minority 000 0000 000000 0
To view ProtoLytic’s complete investors history, request access »